Get started
Author

Esteban Cardenas-Duran

Observed names: Esteban Cardenas Duran, Esteban Cardenas‐Duran, Esteban Cárdenas Durán, Esteban Cárdenas-Durán
Observed institution: Mexican Social Security Institute
ORCID: 0009-0000-1594-9145
Observed ORCID: 0009-0000-1594-9145
OpenAlex ID: A5148377820
DAS28 y SDAI: discordancia esperada entre índices que no miden lo mismo
2026 · Hefziba Lorences-Noguera, Esteban Cárdenas-Durán · Reumatología Clínica
Sesgo de verificación parcial en la evaluación de vida real de la escala PURE-4 para artritis psoriásica
2026 · Hefziba Lorences Noguera, Esteban Cárdenas-Durán · Reumatología Clínica
In Silico Validation and Model-Selection Bias in an Artificial Intelligence-Identified Cardiac Biomarker Linking PCOS and Ischaemic Injury
2026 · Hefziba Lorences-Noguera, Esteban Cardenas-Duran · QJM
Pre-Analytical Variability and Confounding by Tumor Burden in a Lactate-Based Immune Evasion Biomarker in Melanoma
2026 · Hefziba Lorences-Noguera, Esteban Cardenas-Duran · QJM
Competing risks considerations in trends of cause-specific mortality among UK dialysis patients
2026 · Hefziba Lorences Noguera, Esteban Cardenas-Duran · QJM
Age-period-cohort confounding in a two-decade comparison of healthy life expectancy among China’s oldest-old
2026 · Hefziba Lorences-Noguera, Esteban Cardenas-Duran · QJM
Confounding by indication and outcome ascertainment in the reported cardioprotective effect of PCSK9 inhibitors on incident heart failure
2026 · Hefziba Lorences Noguera, Esteban Cárdenas-Durán · QJM
Incomplete adjustment for cardiovascular risk factors in a capillaroscopy-based mortality analysis of Raynaud’s phenomenon
2026 · Hefziba Lorences Noguera, Esteban Cárdenas Durán · Rheumatology International
Correlation is not agreement: the discordance threshold for patient and physician global assessments in systemic sclerosis requires reliability‐based validation: comment on the article by Romich et al
2026 · Hefziba Lorences‐Noguera, Esteban Cardenas‐Duran · Arthritis Care & Research
PDF
Healthy-adherer bias may confound the association between PCSK9 inhibitors and incident heart failure
2026 · Esteban Cardenas-Duran, Hefziba Lorences-Noguera · QJM
Discordant numerator reporting for prior osteoporosis diagnosis and treatment in an opportunistic CTPA screening study
2026 · Hefziba Lorences Noguera, Esteban Cardenas-Duran, et al. · QJM
Discordant Internal and External Validation Performance in a Multicenter Nomogram for Overlap Syndrome in Systemic Lupus Erythematosus
2026 · Hefziba Lorences Noguera, Esteban Cardenas‐Duran · International Journal of Rheumatic Diseases
PDF
Comentarios metodológicos sobre: «Influence of oncostatin M and leukemia inhibitor factor on sarcopenia in individuals with cancer and malnutrition»
2026 · Hefziba Lorences Noguera, Esteban Cárdenas Durán · Endocrinología Diabetes y Nutrición
Capilaroscopia en las vasculitis sistémicas primarias: relevancia de la heterogeneidad del tamaño vascular y la correlación clínica cutánea
2026 · Hefziba Lorences Noguera, Esteban Cárdenas Durán · Reumatología Clínica
Disentangling population ageing from epidemiological change in the rising burden of PM2.5-attributable non-communicable disease in older adults
2026 · Hefziba Lorences Noguera, Esteban Cardenas-Duran · QJM
External validity and performance metrics in a metabolomics-enhanced prediction model for residual pulmonary vascular obstruction
2026 · Hefziba Lorences Noguera, Esteban Cárdenas-Durán · QJM
Symptom-day counts may overstate the clinical benefit of Bifidobacterium lactis XLTG11 in infants
2026 · Esteban Cardenas-Duran, Hefziba Lorences-Noguera · QJM
Channeling by phenotype: does the obesity paradox in COPD confound the respiratory benefits attributed to GLP-1 receptor agonists?
2026 · Esteban Cardenas-Duran, Hefziba Lorences-Noguera · QJM
Diabetes as an unmeasured effect modifier in population-wide blood pressure targets: evidence from the same CHARLS cohort
2026 · Esteban Cardenas-Duran, Hefziba Lorences-Noguera · QJM
A regional benchmark already exists: Mexico’s 2026 dengue protocol falls short of Latin America’s own standard
2026 · Esteban Cardenas-Duran, Hefziba Lorences-Noguera · QJM
Comment on: Annual gout flare frequency as a marker of sustained cardiovascular risk: a clinical threshold for risk stratification
2026 · Hefziba Lorences-Noguera, Esteban Cardenas-Duran · Rheumatology
Drug-induced hyponatraemia in Internal Medicine—The case for standardized causality attribution and biochemical phenotyping
2026 · Esteban Cardenas Duran, Hefziba Lorences Noguera · Nefrología
Lung cancer disparities: infrastructure, not just eligibility, drives the global gap
2026 · Esteban Cardenas-Duran, Hefziba Lorences-Noguera, et al. · QJM
Works count: 23
Citation count:
H-index:
I10-index:
Year
Topic
Type